Lucid Diagnostics Secures First Positive Commercial Insurance Coverage Policy for its EsoGuard® Esophageal DNA Test
Press Releases
March 13, 2025

Lucid Diagnostics Secures First Positive Commercial Insurance Coverage Policy for its EsoGuard® Esophageal DNA Test

Regional Blue Cross Blue Shield plan will cover non-invasive screening of esophageal precancer and cancer

bradford

The Bradford Era

More by this Author
Local & Social